Retrospective Study of the Epidemiology and Clinical Manifestations of Cryptococcus gattii Infections in Colombia from 1997–2011

PLoS Neglected Tropical Diseases

Volumn 8, Issue 11, 2014, Pages

  Lizarazo, Jairo ^a   Escandón, Patricia ^b   Agudelo, Clara Inés ^b   Firacative, Carolina ^b,c   Meyer, Wieland ^c   Castañeda, Elizabeth ^b  

^a Hospital Universitario Erasmo Meoz   (Colombia)

^b INSTITUTO NACIONAL DE SALUD   (Colombia)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE; ANTIFUNGAL AGENT;

ADOLESCENT; ADULT; ANTIFUNGAL ACTIVITY; ANTIFUNGAL SUSCEPTIBILITY; ANTIGEN DETECTION; ARTICLE; BACTERIAL VIRULENCE; CHILD; CLINICAL ARTICLE; COLOMBIA; CRYPTOCOCCOSIS; CRYPTOCOCCUS GATTII; DISEASE SURVEILLANCE; DISK DIFFUSION; EPSILOMETER TEST; FEMALE; FOLLOW UP; GENETIC VARIABILITY; HUMAN; IMMUNOCOMPETENCE; INCIDENCE; INFANT; MALE; MIDDLE AGED; MINIMUM INHIBITORY CONCENTRATION; MULTILOCUS SEQUENCE TYPING; NEWBORN; POLYMERASE CHAIN REACTION; PREVALENCE; RETROSPECTIVE STUDY; SCHOOL CHILD; AGED; CLASSIFICATION; GENETICS; ISOLATION AND PURIFICATION; MICROBIOLOGY; PATHOGENICITY; PRESCHOOL CHILD; RISK FACTOR; VIRULENCE; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AMPHOTERICIN B; ANTIFUNGAL AGENTS; CHILD; CHILD, PRESCHOOL; COLOMBIA; CRYPTOCOCCOSIS; CRYPTOCOCCUS GATTII; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MULTILOCUS SEQUENCE TYPING; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; VIRULENCE; YOUNG ADULT;

EID: 84920406979     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0003272     Document Type: Article

References (133)

1. Idnurm A, Bahn YS, Nielsen K, Lin X, Fraser JA, et al. (2005) Deciphering the model pathogenic fungus Cryptococcus neoformans. Nat Rev Microbiol 3: 753–764.
2. Kwon-Chung KJ, Boekhout T, Fell JW, Diaz M, (2002) Proposal to conserve the name Cryptococcus gattii against C. hondurianus and C. bacillisporus (Basidiomycota, Hymenomycetes, Tremellomycetidae). Taxon 51: 804–806.
3. Kwon-Chung KJ, Polacheck I, Bennett JE, (1982) Improved diagnostic medium for separation of Cryptococcus neoformans var. neoformans (serotypes A and D) and Cryptococcus neoformans var. gattii (serotypes B and C). J Clin Microbiol 15: 535–537.
4. Park BJ, Wannemuehler KA, Marston BJ, Govender N, Pappas PG, et al. (2009) Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS 23: 525–530.
5. Kidd SE, Hagen F, Tscharke RL, Huynh M, Bartlett KH, et al. (2004) A rare genotype of Cryptococcus gattii caused the cryptococcosis outbreak on Vancouver Island (British Columbia, Canada). Proc Natl Acad Sci U S A 101: 17258–17263.
6. Byrnes EJ, 3rdLi W, Lewit Y, Ma H, Voelz K, et al. (2010) Emergence and pathogenicity of highly virulent Cryptococcus gattii genotypes in the northwest United States. PLoS Pathog 6: e1000850.
7. Hagen F, Ceresini PC, Polacheck I, Ma H, van Nieuwerburgh F, et al. (2013) Ancient dispersal of the human fungal pathogen Cryptococcus gattii from the Amazon rainforest. PLoS One 7: e71148.
8. Engelthaler DM, Hicks ND, Gillece JD, Roe CC, Schupp JM, et al. (2014) Cryptococcus gattii in North American Pacific Northwest: whole-population genome analysis provides insights into species evolution and dispersal. mBio 5: e01464–14.
9. Kwon-Chung KJ, Bennett JE, (1984) Epidemiologic differences between the two varieties of Cryptococcus neoformans. Am J Epidemiol 120: 123–130.
10. Hagen F, Colom MF, Swinne D, Tintelnot K, Iatta R, et al. (2012) Autochthonous and dormant Cryptococcus gattii infections in Europe. Emerg Infect Dis 18: 1618–1624.
11. Gattii F, Eeckels R, (1970) An atypical strain of Cryptococcus neoformans (San Felice) Vuillemin 1894. Part I. Description of the disease and of the strain. Ann Soc Belges Med Trop Parasitol Mycol 50: 689–694.
12. Barnett JA, (2010) A history of research on yeasts 14: medical yeasts part 2, Cryptococcus neoformans. Yeast 27: 875–904.
13. Springer DJ, Chaturvedi V, (2010) Projecting global occurrence of Cryptococcus gattii. Emerg Infect Dis 16: 14–20.
14. Chaturvedi V, Chaturvedi S, (2011) Cryptococcus gattii: a resurgent fungal pathogen. Trends Microbiol 19: 564–571.
15. Meyer W, Castañeda A, Jackson S, Huynh M, Castañeda E, et al. (2003) Molecular typing of IberoAmerican Cryptococcus neoformans isolates. Emerg Infect Dis 9: 189–195.
16. Meyer W, Aanensen DM, Boekhout T, Cogliati M, Diaz MR, et al. (2009) Consensus multi-locus sequence typing scheme for Cryptococcus neoformans and Cryptococcus gattii. Med Mycol 47: 561–570.
17. Meyer W, Gilgado F, Ngamskulrungroj P, Trilles L, Hagen F, et al. Molecular typing of the Cryptococcus neoformans/Cryptococcus gattii species complex (2011) In: Heitman J, Kozel TR, Kwon-Chung J, Perfect JR, Casadevall A. Cryptococcus: form human pathogen to model yeast. Washington D.C.: ASM Press. pp 327–357.
18. Bovers M, Hagen F, Kuramae EE, Diaz MR, Spanjaard L, et al. (2006) Unique hybrids between fungal pathogens Cryptococcus neoformans and Cryptococcus gattii. FEMS Yeast Res 6: 599–607.
19. Aminnejad M, Diaz M, Arabatzis M, Castañeda E, Lazera M, et al. (2012) Identification of novel hybrids between Cryptococcus neoformans var. grubii VNI and Cryptococcus gattii VGII. Mycopathologia 173: 337–46.
20. Lizarazo J, Linares M, de Bedout C, Restrepo A, Agudelo CI, et al. (2007) Estudio clínico y epidemiológico de la criptococosis en Colombia: resultados de nueve años de la encuesta nacional, 1997–2005. Biomédica 27: 94–109.
21. Escandón P, de Bedout C, Lizarazo J, Agudelo CI, Tobón A, et al. (2012) Criptococosis en Colombia: resultados de la encuesta nacional, 2006–2010. Biomédica 32: 386–398.
22. Departamento Administrativo Nacional de Estadística (DANE) (2012) http://www.dane.gov.co/index.php?option = com_content&view = article&id = 75&Itemid = 72 consulted June 11, 2012.
23. Halliday CL, Carter DA, (2003) Clonal reproduction and limited dispersal in an environmental population of Cryptococcus neoformans var. gattii isolates from Australia. J Clin Microbiol 41: 703–711.
24. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, et al. (2011) MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol 28: 2731–2739.
25. Simpson EH, (1949) Measurement of diversity. Nature 163: 688.
26. Rozenbaum R, Gonçalves AJ, (1994) Clinical epidemiological study of 171 cases of cryptococcosis. Clin Infect Dis 18: 369–380.
27. Trilles L, Lazéra Mdos S, Wanke B, Oliveira RV, Barbosa GG, et al. (2008) Regional pattern of the molecular types of Cryptococcus neoformans and Cryptococcus gattii in Brazil. Mem Inst Oswaldo Cruz 103: 455–462.
28. Corrêa Mdo P, Oliveira EC, Duarte RR, Pardal PP, Oliveira Fde M, et al. (1999) Cryptococcosis in children in the State of Pará, Brazil. Rev Soc Bras Med Trop 32: 505–508.
29. Santos WR, Meyer W, Wanke B, Costa SP, Trilles L, et al. (2008) Primary endemic Cryptococcosis gattii by molecular type VGII in the state of Pará, Brazil. Mem Inst Oswaldo Cruz 103: 813–818.
30. Freire AK, dos Santos Bentes A, de Lima Sampaio I, Matsuura AB, Ogusku MM, et al. (2012) Molecular characterization of the causative agents of cryptococcosis in patients of a tertiary healthcare facility in the state of Amazonas-Brazil. Mycoses 55: e145–50 doi: 10.1111/j.1439-0507.2012.02173.x
31. Da Silva BK, Freire AK, Bentes Ados S, Sampaio Ide L, Santos LO, et al. (2012) Characterization of clinical isolates of the Cryptococcus neoformans-Cryptococcus gattii species complex from the Amazonas State in Brazil. Rev Iberoam Micol 29: 40–43.
32. Martins LM, Wanke B, Lazéra Mdos S, Trilles L, Barbosa GG, et al. (2011) Genotypes of Cryptococcus neoformans and Cryptococcus gattii as agents of endemic cryptococcosis in Teresina, Piauí (Northeastern Brazil). Mem Inst Oswaldo Cruz 106: 725–730.
33. Matos CS, de Souza Andrade A, Oliveira NS, Barros TF, (2012) Microbiological characteristics of clinical isolates of Cryptococcus spp. in Bahia, Brazil: molecular types and antifungal susceptibilities. Eur J Clin Microbiol Infect Dis 31: 1647–1652.
34. Tsujisaki RA, Paniago AM, Lima Júnior MS, Alencar Dde S, Spositto FL, et al. (2013) First molecular typing of cryptococcemia-causing Cryptococcus in central-west Brazil. Mycopathologia 176: 267–272.
35. Souza LK, Fernandes O de F, Kobayashi CC, Passos XS, Costa CR, et al. (2005) Antifungal susceptibilities of clinical and environmental isolates of Cryptococcus neoformans in Goiânia city, Goiás, Brazil. Rev Inst Med Trop Sao Paulo 47: 253–256.
36. Souza LK, Souza Junior AH, Costa CR, Faganello J, Vainstein MH, et al. (2010) Molecular typing and antifungal susceptibility of clinical and environmental Cryptococcus neoformans species complex isolates in Goiania, Brazil. Mycoses 53: 62–67.
37. Hasimoto e Souza LK, Costa CR, Fernandes Ode F, Abrão FY, Silva TC, et al. (2013) Clinical and microbiological features of cryptococcal meningitis. Rev Soc Bras Med Trop 46: 343–347.
38. Favalessa OC, Lazéra Mdos S, Wanke B, Trilles L, Takahara DT, et al. (2014) Fatal Cryptococcus gattii genotype AFLP6/VGII infection in a HIV-negative patient: case report and a literature review. Mycoses Jun 30 : doi: 10.1111/myc.12210
39. Lindenberg Ade S, Chang MR, Paniago AM, Lazéra Mdos S, Moncada PM, et al. (2008) Clinical and epidemiological features of 123 cases of cryptococcosis in Mato Grosso do Sul, Brazil. Rev Inst Med Trop Sao Paulo 50: 75–78.
40. Favalessa OC, Ribeiro LC, Tadano T, Fontes CJ, Dias FB, et al. (2009) First description of phenotypic profile and in vitro drug susceptibility of Cryptococcus spp. yeast isolated from HIV-positive and HIV-negative patients in State of Mato Grosso. Rev Soc Bras Med Trop 42: 661–665.
41. Ohkusu M, Tangonan N, Takeo K, Kishida E, Ohkubo M, et al. (2002) Serotype, mating type and ploidy of Cryptococcus neoformans strains isolated from patients in Brazil. Rev Inst Med Trop Sao Paulo 44: 299–302.
42. Almeida AM, Matsumoto MT, Baeza LC, de Oliveira E Silva RB, Kleiner AA, et al. (2007) Molecular typing and antifungal susceptibility of clinical sequential isolates of Cryptococcus neoformans from Sao Paulo State, Brazil. FEMS Yeast Res 7: 152–164.
43. Motta A, Almeida GD, Almeida J, Pinto MI, Onorio S, Rossi F, (2010) Cryptococcus: species distribution and susceptibility profile of isolates in a teaching hospital from São Paulo-Brazil. Int J Infect Dis 14: e126 doi:10.1016/j.ijid.2010.02.1764
44. Nascimento E, Bonifácio da Silva ME, Martinez R, von Zeska Kress MR, (2014) Primary cutaneous cryptococcosis in an immunocompetent patient due to Cryptococcus gattii molecular type VGI in Brazil: a case report and review of literature. Mycoses 57: 442–447.
45. Moreira Tde A, Ferreira MS, Ribas RM, Borges AS, (2006) Cryptococcosis: clinical epidemiological laboratorial study and fungi varieties in 96 patients. Rev Soc Bras Med Trop 39: 255–258.
46. Silva PR, Rabelo RA, Terra AP, Teixeira DN, (2008) Susceptibility to antifungal agents among Cryptococcus neoformans varieties isolated from patients at a university hospital. Rev Soc Bras Med Trop 41: 158–162.
47. Mora DJ, da Cunha Colombo ER, Ferreira-Paim K, Andrade-Silva LE, Nascentes GA, et al. (2012) Clinical, epidemiological and outcome features of patients with cryptococcosis in Uberaba, Minas Gerais, Brazil. Mycopathologia 173: 321–327.
48. Casali AK, Goulart L, Rosa e Silva LK, Ribeiro AM, Amaral AA, et al. (2003) Molecular typing of clinical and environmental Cryptococcus neoformans isolates in the Brazilian state Rio Grande do Sul. FEMS Yeast Res 3: 405–415.
49. López-Martínez R, Soto-Hernández JL, Ostrosky-Zeichner L, Castanón-Olivares LR, Angeles-Morales V, et al. (1996) Cryptococcus neoformans var. gattii among patients with cryptococcal meningitis in Mexico. First observations. Mycopathologia 134: 61–64.
50. Castañón-Olivares LR, Arreguín-Espinosa R, Ruiz-Palacios SG, López-Martínez R, (2000) Frequency of Cryptococcus species and varieties in Mexico and their comparison with some Latin American countries. Rev Latinoam Microbiol 42: 35–40.
51. Castañón-Olivares LR, Martínez KM, Cruz RM, Rivera MA, Meyer W, et al. (2009) Genotyping of Mexican Cryptococcus neoformans and C. gattii isolates by PCR-fingerprinting. Med Mycol 47: 713–721.
52. Villanueva E, Mendoza M, Torres E, Albornoz MB, (1989) Serotipificación de 27 cepas de Cryptococcus neoformans aisladas en Venezuela. Acta Científica Venezolana 40: 151–154.
53. Pérez C, Dolande M, Moya M, Roselló A, de Capriles CR, et al. (2008) Cryptococcus neoformans, Cryptococcus gattii: serotypes in Venezuela. Mycopathologia 166: 149–153.
54. Pérez C, Hernández Y, Guzmán ME, Arias F, Nweihed L, et al. (2009) Estudio clínico-epidemiológico de la criptococosis en Venezuela, años 1994-2003. Kasmera 37: 140–147.
55. Debourgogne A, Iriart X, Blanchet D, Veron V, Boukhari R, et al. (2011) Characteristics and specificities of Cryptococcus infections in French Guiana, 1998-2008. Med Mycol 49: 864–871.
56. Bava AJ, Negroni R, (1992) Características epidemiológicas de 105 casos de criptococosis diagnosticados en la República Argentina entre 1981–1990. Rev Inst Med trop Sao Paulo 34: 335–340.
57. Bava AJ, Robles AM, Negroni R, Arechavala A, Bianchi M, (1997) Estudio de algunos aspectos epidemiológicos de 253 casos de criptococosis. Rev Iberoam Micol 14: 111–114.
58. Bustamante B, Swinne D, (1998) Aislamiento de Cryptococcus neoformans variedad gattii en dos pacientes peruanos. Rev Iberoam Micol 15: 22–24.
59. Lizarazo J, Chaves O, Peña Y, Escandón P, Agudelo CI, et al. (2012) Comparación de los hallazgos clínicos y de supervivencia entre pacientes VIH positivos y VIH negativos con criptococosis meníngea en un hospital del tercer nivel. Acta Med Colomb 37: 49–61.
60. Cattana ME, Tracogna MF, Fernández MS, Carol Rey MC, Sosa MA, et al. (2013) Genotipificación de aislamientos clínicos del complejo Cryptococcus neoformans/Cryptococcus gattii obtenidos en el Hospital «Dr. Julio C. Perrando», de la ciudad de Resistencia (Chaco, Argentina). Rev Argent Microbiol 45: 89–92.
61. Illnait-Zaragozí MT, Ortega-Gonzalez LM, Hagen F, Martínez-Machin GF, Meis JF, (2013) Fatal Cryptococcus gattii genotype AFLP5 infection in an immunocompetent Cuban patient. Med Mycol Case Rep 9: 48–51.
62. Hoang LM, Maguire JA, Doyle P, Fyfe M, Roscoe DL, (2004) Cryptococcus neoformans infections at Vancouver Hospital and Health Sciences Centre (1997–2002): epidemiology, microbiology and histopathology. J Med Microbiol 53: 935–940.
63. Galanis E, Macdougall L, (2010) Epidemiology of Cryptococcus gattii, British Columbia, Canada, 1999–2007. Emerg Infect Dis 16: 251–257.
64. Lockhart SR, Iqbal N, Harris JR, Grossman NT, DeBess E, et al. (2013) Cryptococcus gattii in the United States: genotypic diversity of human and veterinary isolates. PLoS One 8: e74737.
65. Byrnes EJ, 3rdLi W, Lewit Y, Ma H, Voelz K, et al. (2010) Emergence and pathogenicity of highly virulent Cryptococcus gattii genotypes in the northwest United States. PLoS Pathog 6: e1000850.
66. Byrnes EJ, 3rdLi W, Ren P, Lewit Y, Voelz K, et al. (2011) A diverse population of Cryptococcus gattii molecular type VGIII in southern Californian HIV/AIDS patients. PLoS Pathog 7: e1002205.
67. Chaturvedi S, Dyavaiah M, Larsen RA, Chaturvedi V, (2005) Cryptococcus gattii in AIDS patients, southern California. Emerg Infect Dis 11: 1686–1692.
68. Tintelnot K, Lemmer K, Losert H, Schär G, Polak A, (2004) Follow-up of epidemiological data of cryptococcosis in Austria, Germany and Switzerland with special focus on the characterization of clinical isolates. Mycoses 47: 455–464.
69. Viviani MA, Cogliati M, Esposto MC, Lemmer K, Tintelnot K, et al. (2006) Molecular analysis of 311 Cryptococcus neoformans isolates from a 30-month ECMM survey of cryptococcosis in Europe. FEMS Yeast Res 6: 614–619.
70. Dromer F, Mathoulin S, Dupont B, Laporte A, (1996) Epidemiology of cryptococcosis in France: a 9-year survey (1985–1993). French Cryptococcosis Study Group. Clin Infect Dis 23: 82–90.
71. Maduro AP, Mansinho K, Teles F, Silva I, Meyer W, et al. (2013) Insights on the genotype distribution among Cryptococcus neoformans and C. gattii Portuguese clinical isolates. Curr Microbiol DOI 10.1007/s00284-013-0452-0.
72. Velegraki A, Kiosses VG, Pitsouni H, Toukas D, Daniilidis VD, et al. (2001) First report of Cryptococcus neoformans var. gattii serotype B from Greece. Med Mycol 39: 419–422.
73. Colom MF, Frasés S, Ferrer C, Jover A, Andreu M, et al. (2005) First case of human cryptococcosis due to Cryptococcus neoformans var. gattii in Spain. J Clin Microbiol 43: 3548–3550.
74. Hagen F, van Assen S, Luijckx GJ, Boekhout T, Kampinga GA, (2010) Activated dormant Cryptococcus gattii infection in a Dutch tourist who visited Vancouver Island (Canada): a molecular epidemiological approach. Med Mycol 48: 528–531.
75. Iatta R, Hagen F, Fico C, Lopatriello N, Boekhout T, et al. (2012) Cryptococcus gattii infection in an immunocompetent patient from Southern Italy. Mycopathologia 174: 87–92.
76. Litvintseva AP, Thakur R, Reller LB, Mitchell TG, (2005) Prevalence of clinical isolates of Cryptococcus gattii serotype C among patients with AIDS in Sub-Saharan Africa. J Infect Dis 192: 888–892.
77. Steele KT, Thakur R, Nthobatsang R, Steenhoff AP, Bisson GP, (2010) In-hospital mortality of HIV-infected cryptococcal meningitis patients with C. gattii and C. neoformans infection in Gaborone, Botswana. Med Mycol 48: 1112–1115.
78. Swinne D, Nkurikiyinfura JB, Muyembe TL, Swinne D, (1986) Clinical isolates of Cryptococcus neoformans from Zaire. Eur J Clin Microbiol 5: 50–51.
79. Bii CC, Makimura K, Abe S, Taguchi H, Mugasia OM, et al. (2007) Antifungal drug susceptibility of Cryptococcus neoformans from clinical sources in Nairobi, Kenya. Mycoses 50: 25–30.
80. Mdodo R, Moser SA, Jaoko W, Baddley J, Pappas P, et al. (2011) Antifungal susceptibilities of Cryptococcus neoformans cerebrospinal fluid isolates from AIDS patients in Kenya. Mycoses 54: e438–42.
81. Bogaerts J, Rouvroy D, Taelman H, Kagame A, Aziz MA, et al. (1999) AIDS-associated cryptococcal meningitis in Rwanda (1983–1992): epidemiologic and diagnostic features. J Infect 39: 32–37.
82. Morgan J, McCarthy KM, Gould S, Fan K, Arthington-Skaggs B, et al. (2006) Cryptococcus gattii infection: characteristics and epidemiology of cases identified in a South African province with high HIV seroprevalence, 2002–2004. Clin Infect Dis 43: 1077–1080.
83. Meiring ST, Quan VC, Cohen C, Dawood H, Karstaedt AS, et al. (2012) A comparison of cases of paediatric-onset and adult-onset cryptococcosis detected through population-based surveillance, 2005–2007. AIDS 26: 2307–2314.
84. Heyderman RS, Gangaidzo IT, Hakim JG, Mielke J, Taziwa A, et al. (1998) Cryptococcal meningitis in human immunodeficiency virus-infected patients in Harare, Zimbabwe. Clin Infect Dis 26: 284–289.
85. Chen J, Varma A, Diaz MR, Litvintseva AP, Wollenberg KK, et al. (2008) Cryptococcus neoformans strains and infection in apparently immunocompetent patients, China. Emerg Infect Dis 14: 755–762.
86. Li M, Liao Y, Chen M, Pan W, Weng L, (2012) Antifungal susceptibilities of Cryptococcus species complex isolates from AIDS and non-AIDS patients in Southeast China. Braz J Infect Dis 16: 175–179.
87. Lui G, Lee N, Ip M, Choi KW, Tso YK, et al. (2006) Cryptococcosis in apparently immunocompetent patients. QJM 99: 143–151.
88. Liaw SJ, Wu HC, Hsueh PR, (2010) Microbiological characteristics of clinical isolates of Cryptococcus neoformans in Taiwan: serotypes, mating types, molecular types, virulence factors, and antifungal susceptibility. Clin Microbiol Infect 16: 696–703.
89. Tseng HK, Liu CP, Ho MW, Lu PL, Lo HJ, et al. (2013) Microbiological, epidemiological, and clinical characteristics and outcomes of patients with cryptococcosis in Taiwan, 1997–2010. PLoS One 17;8: e61921.
90. Choi YH, Ngamskulrungroj P, Varma A, Sionov E, Hwang SM, et al. (2010) Prevalence of the VNIc genotype of Cryptococcus neoformans in non-HIV-associated cryptococcosis in the Republic of Korea. FEMS Yeast Res 10: 769–778.
91. Hwang SM, (2012) Molecular typing of clinical Cryptococcus gattii isolates in Korea. J of Bacteriol Virol 42: 152–155.
92. Padhye AA, Chakrabarti A, Chander J, Kaufman L, (1993) Cryptococcus neoformans var. gattii in India. J Med Vet Mycol 31: 165–168.
93. Banerjee U, Datta K, Casadevall A, (2004) Serotype distribution of Cryptococcus neoformans in patients in a tertiary care center in India. Med Mycol 42: 181–186.
94. Jain N, Wickes BL, Keller SM, Fu J, Casadevall A, et al. (2005) Molecular epidemiology of clinical Cryptococcus neoformans strains from India. J Clin Microbiol 43: 5733–5742.
95. Nagarathna S, Veena Kumari HB, Arvind N, Divyalakshmi A, Chandramuki A, et al. (2010) Prevalence of Cryptococcus gattii causing meningitis in a tertiary neurocare center from south India: A pilot study. Indian J Pathol Microbiol 53: 855–856.
96. Tay ST, Rohani MY, Hoo TS, Hamimah H, (2010) Epidemiology of cryptococcosis in Malaysia. Mycoses 53: 509–514.
97. Chan M, Lye D, Win MK, Chow A, Barkham T, (2014) Clinical and microbiological characteristics of cryptococcosis in Singapore: predominance of Cryptococcus neoformans compared with Cryptococcus gattii. Int J Infect Dis 11: 110–115.
98. Poonwan N, Mikami Y, Poosuwan S, Boon-Long J, Mekha N, et al. (1997) Serotyping of Cryptococcus neoformans strains isolated from clinical specimens in Thailand and their susceptibility to various antifungal agents. Eur J Epidemiol 13: 335–340.
99. Kaocharoen S, Ngamskulrungroj P, Firacative C, Trilles L, Piyabongkarn D, et al. (2013) Molecular epidemiology reveals genetic diversity amongst isolates of the Cryptococcus neoformans/C. gattii species complex in Thailand. PLoS Negl Trop Dis 7: e2297.
100. Chau TT, Mai NH, Phu NH, Nghia HD, Chuong LV, et al. (2010) A prospective descriptive study of cryptococcal meningitis in HIV uninfected patients in Vietnam - high prevalence of Cryptococcus neoformans var grubii in the absence of underlying disease. BMC Infect Dis 10: 199.
101. Day JN1, Hoang TN, Duong AV, Hong CT, Diep PT, et al. (2011) (2011) Most cases of cryptococcal meningitis in HIV-uninfected patients in Vietnam are due to a distinct amplified fragment length polymorphism-defined cluster of Cryptococcus neoformans var. grubii VN1. J Clin Microbiol 49: 658–664.
102. Tsunemi T, Kamata T, Fumimura Y, Watanabe M, Yamawaki M, et al. (2001) Immunohistochemical diagnosis of Cryptococcus neoformans var. gattii infection in chronic meningoencephalitis: the first case in Japan. Intern Med 40: 1241–1244.
103. Okamoto K, Hatakeyama S, Itoyama S, Nukui Y, Yoshino Y, et al. (2010) Cryptococcus gattii genotype VGIIa infection in man, Japan, 2007. Emerg Infect Dis 16: 1155–1157.
104. Taylor MB, Chadwick D, Barkham T, (2002) First reported isolation of Cryptococcus neoformans var. gattii from a patient in Singapore. J Clin Microbiol 40: 3098–3099.
105. Koh TH, Tan AL, Lo YL, Oh H, (2002) Cryptococcus neoformans var. gattii meningitis in Singapore. Med Mycol 40: 221–223.
106. Lingegowda BP, Koh TH, Ong HS, Tan TT, (2011) Primary cutaneous cryptococcosis due to Cryptococcus gattii in Singapore. Singapore Med J 52: e160–162.
107. Laurenson IF, Trevett AJ, Lalloo DG, Nwokolo N, Naraqi S, et al. (1996) Meningitis caused by Cryptococcus neoformans var. gattii and var. neoformans in Papua New Guinea. Trans R Soc Trop Med Hyg 90: 57–60.
108. Seaton RA, Verma N, Naraqi S, Wembri JP, Warrell DA, (1997) Visual loss in immunocompetent patients with Cryptococcus neoformans var. gattii meningitis. Trans R Soc Trop Med Hyg 91: 44–49.
109. Campbell LT, Fraser JA, Nichols CB, Dietrich FS, Carter D, et al. (2005) Clinical and environmental isolates of Cryptococcus gattii from Australia that retain sexual fecundity. Eukaryot Cell 4: 1410–1419.
110. Ellis DH, (1987) Cryptococcus neoformans var. gattii in Australia. Clin Microbiol 25: 430–431.
111. Chen S, Sorrell T, Nimmo G, Speed B, Currie B, et al. (2000) Epidemiology and host- and variety-dependent characteristics of infection due to Cryptococcus neoformans in Australia and New Zealand. Australasian Cryptococcal Study Group. Clin Infect Dis 31: 499–508.
112. Ngamskulrungroj P, Gilgado F, Faganello J, Litvintseva AP, Leal AL, et al. (2009) Genetic diversity of the Cryptococcus species complex suggests that Cryptococcus gattii deserves to have varieties. PLoS One 4: e5862.
113. Harris J, Lockhart S, Chiller T, (2012) Cryptococcus gattii: where do we go from here? Med Mycol 50: 113–129.
114. Laurenson IF, Lalloo DG, Naraqi S, Seaton RA, Trevett AJ, et al. (1997) Cryptococcus neoformans in Papua New Guinea: a common pathogen but an elusive source. J Med Vet Mycol 35: 437–440.
115. Chen SC, Slavin MA, Heath CH, Playford EG, Byth K, et al. (2012) Clinical manifestations of Cryptococcus gattii infection: determinants of neurological sequelae and death. Clin Infect Dis 55: 789–798.
116. Chowdhary A, Randhawa HS, Boekhout T, Hagen F, Klaassen CH, et al. (2012) Temperate climate niche for Cryptococcus gattii in Northern Europe. Emerg Infect Dis 18: 172–174.
117. Lizarazo J, Mendoza M, Palacios D, Vallejo A, Bustamante A, et al. (2000) Criptococosis ocasionada por Cryptococcus neoformans variedad gattii. Acta Med Colomb 25: 171–178.
118. Mitchell DH, Sorrell TC, Allworth AM, Heath CH, McGregor AR, et al. (1995) Cryptococcal disease of the CNS in immunocompetent hosts: influence of cryptococcal variety on clinical manifestations and outcome. Clin Infect Dis 20: 611–616.
119. Speed B, Dunt D, (1995) Clinical and host differences between infections with the two varieties of Cryptococcus neoformans. Clin Infect Dis 21: 28–34.
120. MacDougall L, Fyfe M, Romney M, Starr M, Galanis E, (2011) Risk factors for Cryptococcus gattii infection, British Columbia, Canada. Emerg Infect Dis 17: 193–199.
121. Harris JR, Lockhart SR, Debess E, Marsden-Haug N, Goldoft M, et al. (2011) Cryptococcus gattii in the United States: clinical aspects of infection with an emerging pathogen. Clin Infect Dis 53: 1188–1195.
122. Cheng PY, Sham A, Kronstad JW, (2009) Cryptococcus gattii isolates from the British Columbia cryptococcosis outbreak induce less protective inflammation in a murine model of infection than Cryptococcus neoformans. Infect Immun 77: 4284–4294.
123. Huston SM, Li SS, Stack D, Timm-McCann M, Jones GJ, et al. (2013) Cryptococcus gattii is killed by dendritic cells, but evades adaptive immunity by failing to induce dendritic cell maturation. J Immunol 191: 249–261.
124. Angkasekwinai P, Sringkarin N, Supasorn O, Fungkrajai M, Wang YH, et al. (2014) Cryptococcus gattii infection dampens Th1/Th17 responses by attenuating dendritic cell function and pulmonary chemokine expression in the immunocompetent hosts. Infect Immun pii: IAI.01773–14.
125. Fox DL, Müller NL, (2005) Pulmonary cryptococcosis in immunocompetent patients: CT findings in 12 patients. Am J Roentgenol 185: 622–626.
126. Sorrell TC, Chen SC, Phillips P, Marr KA (2011) Clinical perspectives on Cryptococcus neoformans and Cryptococcus gattii: implications for diagnosis and management. In: Heitman J, Kozel TR, Kwon-Chung KJ, Perfect JR, Casadevall A. Cryptococcus: from human pathogen to model yeast. ASM Press, Washington DC, 595–606.
127. Lee YC, Wang JT, Sun HY, Chen YC, (2011) Comparisons of clinical features and mortality of cryptococcal meningitis between patients with and without human immunodeficiency virus infection. J Microbiol Immunol Infect 44: 338–345.
128. Walraven CJ, Gerstein W, Hardison SE, Wormley F, Lockhart SR, et al. (2011) Fatal disseminated Cryptococcus gattii infection in New Mexico. PLoS One 6: e28625.
129. Carriconde F, Gilgado F, Arthur I, Ellis D, Malik R, et al. (2011) Clonality and α-a recombination in the Australian Cryptococcus gattii VGII population–an emerging outbreak in Australia. PLoS One 6: e16936.
130. Escandón P, Sánchez A, Martínez M, Meyer W, Castañeda E, (2006) Molecular epidemiology of clinical and environmental isolates of the Cryptococcus neoformans species complex reveals a high genetic diversity and the presence of the molecular type VGII mating type a in Colombia. FEMS Yeast Res 6: 625–635.
131. Callejas A, Ordoñez N, Rodriguez MC, Castañeda E, (1998) First isolation of Cryptococcus neoformans var. gattii, serotype C, from the environment in Colombia. Med Mycol 36: 341–344.
132. Firacative C, Torres G, Rodríguez MC, Escandón P, (2011) First environmental isolation of Cryptococcus gattii serotype B, from Cúcuta, Colombia. Biomédica 31: 118–123.
133. Perfect JR, Dismukes WE, Dromer F, Goldman DL, Graybill JR, et al. (2010) Clinical practice guidelines for the management of cryptococcal disease: 2010 Update by the Infectious Diseases Society of America. Clin Infect Dis 50: 291–322.